Tag: ATTENTION LATE
Randomised trial results suggest tenecteplase’s late-window benefits do not extend to...
While new data have provided solid evidence on tenecteplase’s benefits in non-large vessel occlusion (LVO) ischaemic stroke patients presenting within 24 hours from symptom...
